{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:21:56Z","timestamp":1771298516489,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.maturitas.2008.05.003","type":"journal-article","created":{"date-parts":[[2008,6,25]],"date-time":"2008-06-25T05:59:32Z","timestamp":1214373572000},"page":"170-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss"],"prefix":"10.1016","volume":"60","author":[{"given":"Hee-Jeong","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee-Aee","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2008.05.003_bib1","first-page":"646","article-title":"Consensus development conference: diagnosis, prophylaxis and treatment of osteoporosis","volume":"941","author":"Anonymous","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.maturitas.2008.05.003_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S8756-3282(03)00236-9","article-title":"Is the paradigm shifting?","volume":"33","author":"Heaney","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2008.05.003_bib3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S8756-3282(02)00869-4","article-title":"Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis","volume":"31","author":"Eriksen","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2008.05.003_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.7326\/0003-4819-128-4-199802150-00001","article-title":"Alendronate prevents postmenopausal bone loss in women without osteoporosis. A double-blind, randomized, controlled trial. Alendronate Osteoporosis Prevention Study Group","volume":"128","author":"McClung","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2008.05.003_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199802193380801","article-title":"Prevention of bone loss with alendonate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group","volume":"338","author":"Hosking","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2008.05.003_bib6","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2008.05.003_bib7","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jama.1997.03540380073035","article-title":"Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups","volume":"277","author":"Karpf","year":"1997","journal-title":"JAMA"},{"issue":"Suppl.","key":"10.1016\/j.maturitas.2008.05.003_bib8","first-page":"18","article-title":"Pharmacokinetics of alendronate: an overview","volume":"101","author":"Lin","year":"1999","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.maturitas.2008.05.003_bib9","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1359\/jbmr.2002.17.11.1988","article-title":"Two-years results of once-weekly administration of alendronate 70mg for the treatment of postmenopausal osteoporosis","volume":"17","author":"Greenspan","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.maturitas.2008.05.003_bib10","first-page":"1","article-title":"Therapeutic equivalence of alendronate 70mg once-weekly and alendronate 10mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group","volume":"12","author":"Schnitzer","year":"2000","journal-title":"Aging (Milano)"},{"key":"10.1016\/j.maturitas.2008.05.003_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00198-005-0035-4","article-title":"Changes in the RANK ligand\/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients","volume":"17","author":"Dobnig","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2008.05.003_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s001980050214","article-title":"A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. The Alendronate Phase III Osteoporosis Treatment Research Group","volume":"19","author":"Shiraki","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2008.05.003_bib13","first-page":"265","article-title":"Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers","volume":"82","author":"Bone","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2008.05.003_bib14","doi-asserted-by":"crossref","first-page":"274S","DOI":"10.1093\/ajcn\/54.1.274S","article-title":"Calcium supplementation and bone loss: a review of controlled clinical trials","volume":"54","author":"Dawson-Hughes","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.maturitas.2008.05.003_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9343(99)80310-6","article-title":"Long-term effects of calcium supplementation on bone loss and fractures in postemenopausal women: a randomized controlled trial","volume":"98","author":"Reid","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.maturitas.2008.05.003_bib16","series-title":"Bisphosphonates for treatment of osteoporosis. Primer on the metabolic bone disease and disorders of mineral metabolism","author":"Watts","year":"2003"},{"key":"10.1016\/j.maturitas.2008.05.003_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.maturitas.2008.05.003_bib18","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.maturitas.2008.05.003_bib19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2265.2004.02090.x","article-title":"The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women","volume":"61","author":"Oh","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.maturitas.2008.05.003_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S8756-3282(00)00291-X","article-title":"Effects of two intermittent alendronate regimens in the prevention or treatment of postemenopausal osteoporosis","volume":"27","author":"Rossini","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2008.05.003_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1081\/ERC-120028385","article-title":"Efficacy of intermittent low dose alendronate in Thai postmenopausal osteoporosis","volume":"30","author":"Chailurkit","year":"2004","journal-title":"Endocr Res"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512208001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512208001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:44:20Z","timestamp":1759913060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512208001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0378512208001278"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2008.05.003","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2008.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}